Download PDF
Thromb Haemost 1963; 10(01): 146-150
DOI: 10.1055/s-0038-1654770
Originalarbeiten — Original Article — Travaux Originaux
Schattauer GmbH

The Effect of Aminopterin Sodium on Plasma Fibrinogen, Antifibrinolysin and Euglobulin Lysis Time[*]

J Frederic Johnson
1   Department of Physiology and Pharmacology, Wayne State University College of Medicine, Detroit, Michigan, USA
,
Rashid A Zeineh
1   Department of Physiology and Pharmacology, Wayne State University College of Medicine, Detroit, Michigan, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
22 June 2018 (online)

    Permissions and Reprints

Summary

The daily oral administration of Aminopterin Sodium to normal dogs was accompanied by an increase in plasma antifibrinolysin concentration, an increase in plasma fibrinogen concentration and a decrease in euglobulin fibrinolytic activity.

* This investigation was supported by a research grant HE-05141 from the National Heart Institute, National Institute of Health, U.S. Public Health Service.


 

  • References

  • 1 Guest M. M, Ware A. G, Seegers W. H. A Quantitative Study of Antifibrinolysin in Chick Plasma: Increase in Antifibrinolysin Activity During Pteroylglutamic Acid Deficiency. Amer. J. Physol. 150: 661 1947;
    PubMedGoogle Scholar
  • 2 Dameshek W, Freedman M. H, Steinberg L. Folic Acid Antagonists in the Treatment of Acute and Subacute Leukemia. Blood 05: 898 1950;
    PubMedGoogle Scholar
  • 3 Stirland R. M, Camb M. B. A Rapid Method of Estimating Fibrinogen. Lancet 01: 672 1956;
    PubMedGoogle Scholar
  • 4 Ware A. G, Guest M. M, Seegers W. H. Fibrinogen: With Special Reference to its Preparation and Certain Properties of the Product. Arch. Biochem. 13: 231 1947;
    PubMedGoogle Scholar
  • 5 Kowalskij E, Kopec M, Niewiarowski S. An Evaluation of the Euglobulin Method for the Determination of Fibrinolysis. J. clin. Path. 12: 215 1959;
    CrossrefPubMedGoogle Scholar
  • 6 Fearnley G. R. Spontaneous Fibrinolysis. Amer. J. of Cardiol. Symposium on Fibrinolysis. 371 August 1960
    PubMedGoogle Scholar
  • 7 Whipple G. H, Hurwitz S. F. Fibrinogen of the Blood as Influenced by the Liver Necrosis of Chloroform Poisoning. J. exp. Med. 13: 136 1911;
    CrossrefPubMedGoogle Scholar
  • 8 Elliot F. A, Buckel M. Fibrinogen Changes in Relation to Cerebrovascular Accidents. Neurology 11: 120 1961;
    CrossrefPubMedGoogle Scholar
  • 9 Ingram G. I. C. Plasma Fibrinogen Concentration in Occlusive Arterial Disease. Edinb. med. J. 59: 94 1952;
    PubMedGoogle Scholar
  • 10 Adelson E, Rheingold J. J, Parker O, Buenaventura A, Crosby W. H. Platelets and Fibrinogen Survival in Normal and Abnormal State of Coagulation. Blood 17: 267 1961;
    PubMedGoogle Scholar
  • 11 Gerdes K, Maurer W. Evaluation of the Life Span of Fibrinogen in Man and Rabbit. Biochem. Z. 328: 552 1957;
    PubMedGoogle Scholar
  • 12 Hammond J. D. S, Verel D. Observations on the Distribution and Biological Half-life of Human Fibrinogen. Brit. J. Haemat. 05: 431 1959;
    CrossrefPubMedGoogle Scholar
  • 13 Madden R. E, Gould R. G. The Turnover Rate of Fibrinogen in the Dog. J. biol. Chem. 196: 641 1952;
    PubMedGoogle Scholar
  • 14 Volwiler W, Goldsworthy P. D, MacMartin M. P, Wood P. A, MacKay I. R, Fermont-Smith K. Biosynthetic Determination with Radioactive Sulfur of Turn-over Rates of Various Plasma Proteins in Normal and Cirrhotic Man. J. clin. Invest. 34: 1126 1955;
    CrossrefPubMedGoogle Scholar